Harnessing grid computing to save women's lives

Breast cancer is the most common cancer in women. In the EU and the US, one in eight will develop it at some point in their lives, and it will kill one in 28. But harnessing the power of the grid could help increase the accuracy of diagnoses.

Mammography examinations save thousands of women's lives every year. However the rate of misdiagnosis can be high – in some instances up to 30%. This is due in part to physical differences across patient populations, differences in equipment and procedures, and difficulty in using computers to help detect changes in breast tissue.

Computer-aided detection of this potentially fatal cancer, especially when used together with the traditional method of visually screening mammograms, can not only shorten the time needed for analysis, but can also help increase the accuracy of diagnoses.

Novel approach to comparative diagnoses
The team in the European IST project MammoGrid, which ended in August 2005, aimed to apply the power of the grid to see if they could more accurately detect breast cancer. The prototype software that resulted is already enabling users – hospitals, doctors, clinicians, radiologists and researchers – to harness the massive capacity of grid computing to run advanced algorithms on digital mammograms, stored Europe-wide.

The project team also developed a geographically distributed, grid-based database of standardised images and associated patient data. Already, there are 30,000 images stored from over 3,000 patients, equally balanced between the University Hospital of Cambridge in the UK and Udine in Italy.

The novelty of the MammoGrid approach lies in the application of grid technologies to medical diagnoses, and in providing the data and tools to enable users to compare new mammograms with existing ones in the grid database. Users can access mammograms from a variety of sources, and also computer-aided detection algorithms to detect micro-calcifications (tiny specks of calcium in the breast that could indicate cancer) and monitor breast density (dense tissue is considered a major risk factor).

Sharing resources and patient data
"The system in its current version allows users to securely share both resources and patient data which has been treated to ensure anonymity," explains project coordinator David Manset of Maat GKnowledge in Madrid, Spain. "It also supports effective co-working and provides the means for powerful comparative analyses through the use of a standard format for mammogram images".

This break-through functionality could lead to major advances in prevention and detection of the disease. It also opens the door to novel, broad-based statistical analyses of the incidence of breast cancer and its different forms.

MammoGrid+ building on the achievements
Since the project ended, a new consortium independent of IST funding has been set up to further develop the prototype and take it closer to market needs. Under Mammogrid+, a new set of partners (including organisations such as CIEMAT (Spain's Energy, Environmental and Technological Research Centre), CERN (Switzerland), SES (health service for the Extremadura region of Spain, representing the hospitals of Infanta Christina, Don Benito and Merida), and the university hospitals of Cambridge and Udine) is building on the results already achieved.

The new project team has set up four separate sites, to simulate the needs of four different hospitals and test the latest project developments. The results from these tests have been evaluated by a panel of two IT experts and five clinicians from the hospitals in Spain’s Extremadura region.

Their feedback is being incorporated into a pre-commercial release of the software (Mammogrid+ version 1.0) in June 2007. This version is being deployed within the five hospitals collaborating in the project – these hospitals will also receive the hardware infrastructure to host the Mammogrid+ suite.

Future plans include broadening the existing database Europe-wide. Already a further hospital, the university hospital of Cork in Ireland, has shown interest in joining the Mammogrid+ network.

"The inclusion of the new hospitals will increase the coverage of the database and make our knowledge more relevant and more accurate," Manset concludes. "This will allow larger and more refined epidemiological studies. In the end, these techniques could help save lives."

Contact:
David Manset
Maat GKnowledge
Calle San Bernardo num 115, 5 izq
E-28015 Madrid
Spain
Tel: +34 68 780 2661
Fax: +34 67 347 9175
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Source: IST Results Portal

For further information, please visit:
www.mammogrid.com

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...